FDA Again Rejects Xarelto for ACS: The FDA first denied rivaroxaban for ACS in July 2012, with the first complete response letter. Although the public is not privy to the contents of the complete response letter, an FDA advisory panel had narrowly rejected Janssen's request in May 2012.
See all stories on this topic »
Get latest organ donor and transplant news goto -transplantviews.blogspot.com
FDA Again Rejects Xarelto for ACS
0 comments:
Post a Comment